Recruiting
Enhancing Brain And Mental Health Through Breathing Practice
The purpose of this study is to evaluate the feasibility of a structured breathing intervention in rural and non-rural adolescents diagnosed with anxiety and depression, recruited from outpatient pediatric and child/adolescent psychiatry clinics.
ClinicalTrials.gov IDNCT07369752
PhaseNA
Enrollment40
SponsorMayo Clinic
Age12 Years
SexALL
Conditions studied
Depressive Disorder, Anxiety, Adolescent
About this study
The purpose of this study is to evaluate the feasibility of a structured breathing intervention in rural and non-rural adolescents diagnosed with anxiety and depression, recruited from outpatient pediatric and child/adolescent psychiatry clinics.
Interventions
- Behavioral: Breathing Intervention — Participants will follow a structured breathing practice (Seokmun Hoheup) that progresses in incremental steps, beginning with 15 minutes, increasing to 30 minutes, and then to 36 minutes per session over the course of the program.
Primary outcomes
- Feasibility of Intervention Measure (FIM) score (4 months)
- Acceptability of Intervention Measure (AIM) score (4 months)
- Intervention Appropriateness Measure (IAM) score (4 months)
- Recruitment feasibility (4 months)
- Retention feasibility (4 months)
Eligibility information
Inclusion Criteria:
* Adolescents between the ages of 12 and 17 who have been diagnosed with a major depressive disorder (mild or moderate) and/or an anxiety disorder.
* Participants may have co-occurring mild to moderate alcohol or drug use problems, provided these do not require immediate specialized treatment or crisis intervention.
* All participants must be receiving care at one of two participating MCHS outpatient psychiatry clinics and may reside in rural area (RUCA code 4-10) or non-rural area.
* Participants must be able to read and understand English, and both parental or guardian consent and adolescent assent will be required.
Exclusion Criteria:
* Current suicidal ideation or self-harm behavior requiring immediate clinical intervention
* Presence of severe psychiatric comorbidities such as psychosis, bipolar disorder, depression with psychotic features, severe alcohol and drug use, or eating disorders.
* Participants with significant cognitive impairment that would interfere with study participation.
Study locations
- Mayo Clinic Health System-Albert Lea, Albert Lea, Minnesota 56007 United States
- Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin 54703 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.